
TY  - JOUR
TI  - Abstracts for the 10th Meeting of the International Liver Transplantation Society, June 9–12, 2004, Kyoto, Japan
JO  - Liver Transplantation
JA  - Liver Transpl
VL  - 10
IS  - 6
SN  - 1527-6465
UR  - https://doi.org/10.1002/lt.20208
DO  - doi:10.1002/lt.20208
SP  - C1
EP  - C146
PY  - 2004
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
VL  - 20
IS  - 10
SN  - 0277-0008
UR  - https://doi.org/10.1592/phco.20.15.1229.34588
DO  - doi:10.1592/phco.20.15.1229.34588
SP  - 1229
EP  - 1301
PY  - 2000
ER  - 

TY  - JOUR
AU  - Titus, Feliu
AU  - Lánez, Miguel J. A.
TI  - 9TH CONGRESS OF THE INTERNATIONAL HEADACHE SOCIETY
JO  - Cephalalgia
VL  - 19
IS  - 4
SN  - 0333-1024
UR  - https://doi.org/10.1046/j.1468-2982.1999.019004251.x
DO  - doi:10.1046/j.1468-2982.1999.019004251.x
SP  - 251
EP  - 475
PY  - 1999
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 39
IS  - S1
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.200990184
DO  - doi:10.1002/eji.200990184
SP  - S332
EP  - S555
PY  - 2009
AB  - Abstract No Abtract
ER  - 

TY  - JOUR
TI  - Abstracts (359 - 460)
JO  - American Journal of Transplantation
VL  - 3
IS  - s5
SN  - 1600-6135
UR  - https://doi.org/10.1034/j.1600-6143.3.s5.015b.x
DO  - doi:10.1034/j.1600-6143.3.s5.015b.x
SP  - 359
EP  - 460
PY  - 2003
ER  - 

TY  - JOUR
TI  - 41st Annual conference of International Society of Paediatric Oncology SIOP 2009, Sao Paulo, Brazil, October 5–9, 2009
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 53
IS  - 5
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.22234
DO  - doi:10.1002/pbc.22234
SP  - 701
EP  - 915
PY  - 2009
ER  - 

TY  - JOUR
AU  - Shah, Keyur B.
AU  - Kop, Willem J.
AU  - Christenson, Robert H.
AU  - Diercks, Deborah B.
AU  - Kuo, Dick
AU  - Henderson, Sue
AU  - Hanson, Karen
AU  - Li, Shu-Ying
AU  - deFilippi, Christopher R.
TI  - Natriuretic peptides and echocardiography in acute dyspnoea: implication of elevated levels with normal systolic function
JO  - European Journal of Heart Failure
JA  - European Journal of Heart Failure
VL  - 11
IS  - 7
SN  - 1388-9842
UR  - https://doi.org/10.1093/eurjhf/hfp075
DO  - doi:10.1093/eurjhf/hfp075
SP  - 659
EP  - 667
KW  - Heart failure
KW  - Natriuretic peptides
KW  - Echocardiography
KW  - Prognosis
PY  - 2009
AB  - Aims Previous evaluations of natriuretic peptide (NP) levels in patients with acute dyspnoea presenting to the emergency department (ED) have selected only a minority of patients for echocardiography. We aimed to evaluate the association between NPs and more subtle echocardiographic findings and to assess the potential for NPs to provide additional prognostic information beyond that provided by echocardiography in ?all-comers? with acute dyspnoea. Methods and results Prospective echocardiograms were performed on 338/412 patients presenting to the ED with acute dyspnoea. B-type natriuretic peptide and NT-proBNP were measured on presentation. Patients were followed-up for 1 year. Decompensated heart failure was diagnosed in 37% of patients and 13% died. The diagnostic accuracy (c-statistic) of BNP and NT-proBNP for identifying LVEF ≤ 40% was 0.88 (P < 0.001) and 0.86 (P < 0.001), respectively. The c-statistics for BNP and NT-proBNP for identifying diastolic dysfunction were 0.67 (P < 0.001) and 0.67 (P < 0.001); but only 0.57 (P = 0.09) and 0.60 (P = 0.02) in patients with LVEF ≥ 50%. Natriuretic peptides, but not LV mass or diastolic parameters, independently predicted mortality at 1 year in all patients and in those with an LVEF ≥ 50%. Conclusion In an acute dyspnoea population with ?all-comers? undergoing echocardiography, NPs correlate strongly with structural abnormalities and identify those with preserved LVEF at highest risk for death. Careful interpretation of elevated NP values is needed in the presence of preserved systolic function.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Internal Medicine Journal
VL  - 39
IS  - s1
SN  - 1444-0903
UR  - https://doi.org/10.1111/j.1445-5994.2009.0s0001.x
DO  - doi:10.1111/j.1445-5994.2009.0s0001.x
SP  - A1
EP  - A33
PY  - 2009
ER  - 

AU  - Saw, Seow Hoon
AU  - Wang, Karen
AU  - Yong, Thomas
AU  - Ramakrishna, Seeram
TI  - Polymeric Nanofibers in Tissue Engineering
SN  - 9783527313013
UR  - https://doi.org/10.1002/9783527610419.ntls0096
DO  - doi:10.1002/9783527610419.ntls0096
PY  - 2009
AB  - Abstract The sections in this article are
ER  - 

TY  - JOUR
TI  - Mini Oral Abstracts
JO  - Nephrology
JA  - Nephrology
VL  - 21
IS  - S2
SN  - 9783527313013
UR  - https://doi.org/10.1111/nep.12887
DO  - doi:10.1111/nep.12887
SP  - 58
EP  - 149
PY  - 2016
ER  - 

TY  - JOUR
TI  - 47th Annual Meeting of the Child Neurology Society
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 84
IS  - S22
SN  - 9783527313013
UR  - https://doi.org/10.1002/ana.25305
DO  - doi:10.1002/ana.25305
SP  - S281
EP  - S428
PY  - 2018
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Acta Physiologica
JA  - Acta Physiol
VL  - 213
IS  - S699
SN  - 9783527313013
UR  - https://doi.org/10.1111/apha.12484
DO  - doi:10.1111/apha.12484
SP  - 68
EP  - 199
PY  - 2015
ER  - 

TY  - JOUR
TI  - Young Investigators Awards Finalists Abstracts
JO  - Pacing and Clinical Electrophysiology
VL  - 26
IS  - 4p2
SN  - 9783527313013
UR  - https://doi.org/10.1046/j.1460-9592.2003.t01-2-00inv.x
DO  - doi:10.1046/j.1460-9592.2003.t01-2-00inv.x
SP  - 990
EP  - 991
PY  - 2003
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Pacing and Clinical Electrophysiology
VL  - 26
IS  - 4p2
SN  - 9783527313013
UR  - https://doi.org/10.1046/j.1460-9592.2003.t01-2-00ora.x
DO  - doi:10.1046/j.1460-9592.2003.t01-2-00ora.x
SP  - 929
EP  - 990
PY  - 2003
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Pacing and Clinical Electrophysiology
VL  - 26
IS  - 4p2
SN  - 9783527313013
UR  - https://doi.org/10.1046/j.1460-9592.2003.t01-2-00pos.x
DO  - doi:10.1046/j.1460-9592.2003.t01-2-00pos.x
SP  - 992
EP  - 1126
PY  - 2003
ER  - 

TY  - JOUR
TI  - 2019 ACCP Annual Meeting
JO  - JACCP:  JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
JA  - J Am Coll Clin Pharm
VL  - 3
IS  - 1
SN  - 9783527313013
UR  - https://doi.org/10.1002/jac5.1204
DO  - doi:10.1002/jac5.1204
SP  - 145
EP  - 391
PY  - 2020
ER  - 

TY  - JOUR
AU  - Potocki, M.
AU  - Breidthardt, T.
AU  - Reichlin, T.
AU  - Hartwiger, S.
AU  - Morgenthaler, N. G.
AU  - Bergmann, A.
AU  - Noveanu, M.
AU  - Freidank, H.
AU  - Taegtmeyer, A. B.
AU  - Wetzel, K.
AU  - Boldanova, T.
AU  - Stelzig, C.
AU  - Bingisser, R.
AU  - Christ, M.
AU  - Mueller, C.
TI  - Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic   peptide in the diagnosis of heart failure
JO  - Journal of Internal Medicine
VL  - 267
IS  - 1
SN  - 9783527313013
UR  - https://doi.org/10.1111/j.1365-2796.2009.02135.x
DO  - doi:10.1111/j.1365-2796.2009.02135.x
SP  - 119
EP  - 129
KW  - dyspnoea
KW  - emergency diagnosis
KW  - heart failure
KW  - MRproANP
KW  - natriuretic peptides
PY  - 2010
AB  - Abstract. Objectives.? The concentration of atrial natriuretic peptide (ANP) in the circulation is approximately 10- to 50- fold higher than B-type natriuretic peptide (BNP). We sought to compare the accuracy of midregional pro-atrial natriuretic peptide (MRproANP) measured with a novel sandwich immunoassay with N-terminal pro-B-type natriuretic peptide (NTproBNP) in the diagnosis of heart failure. Design.? The diagnosis of heart failure was adjudicated by two independent cardiologists using all available clinical data (including BNP levels) in 287 consecutive patients presenting with dyspnoea to the emergency department (ED). MRproANP and NTproBNP levels were determined at presentation in a blinded fashion. Results.? Heart failure was the adjudicated final diagnosis in 154 patients (54%). Median MRproANP was significantly higher in patients with heart failure as compared to patients with other causes of dyspnoea (400 vs. 92?pmol?L?1, P?<?0.001). The diagnostic accuracy of MRproANP was very high with an area under the receiver operating characteristic curve of 0.92 and was comparable with that of NTproBNP (0.92, P?=?0.791). Moreover, MRproANP provided incremental diagnostic information to BNP and NTproBNP in patients presenting with BNP levels in the grey zone between 100 and 500?pg?mL?1. Conclusion.? Midregional pro-atrial natriuretic peptide is as accurate in the diagnosis of heart failure as NTproBNP. MRproANP seems to provide incremental information on top of BNP or NT-proBNP in some subgroups and should be further investigated in other studies.
ER  - 

TY  - JOUR
TI  - Naspe Abstracts
JO  - Pacing and Clinical Electrophysiology
VL  - 26
IS  - 4p2
SN  - 9783527313013
UR  - https://doi.org/10.1046/j.1460-9592.2003.t01-2-00165.x
DO  - doi:10.1046/j.1460-9592.2003.t01-2-00165.x
SP  - 929
EP  - 1126
PY  - 2003
ER  - 

TY  - JOUR
TI  - International Society of Paediatric Oncology, SIOP XXXVII Annual Congress Meeting: Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 45
IS  - 4
SN  - 9783527313013
UR  - https://doi.org/10.1002/pbc.20588
DO  - doi:10.1002/pbc.20588
SP  - 365
EP  - 608
PY  - 2005
ER  - 

TY  - JOUR
TI  - Cardiovascular, Respiratory and Autonomic Control C35-C40 C78-C82 PC32-PC51 PC83-PC106a
JO  - The Journal of Physiology
JA  - The Journal of Physiology
VL  - 567
IS  - suppl
SN  - 9783527313013
UR  - https://doi.org/10.1111/j.1469-7793.2005.tb00556.x
DO  - doi:10.1111/j.1469-7793.2005.tb00556.x
SP  - 20P
EP  - 137P
PY  - 2005
ER  - 
